A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2009030263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2010English

GSK2646264, a Spleen Tyrosine Kinase Inhibitor Attenuates the Release of Histamine in Ex Vivo Human Skin

British Journal of Pharmacology
Pharmacology
2019English

Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor

Prescriber
Pharmacology
2018English

The Tyrosine Kinase Inhibitor Dasatinib Reduces the Growth of Intracellular Mycobacterium Tuberculosis Despite Impairing T-Cell Function

European Journal of Immunology
AllergyImmunology
2018English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2013English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

A Specific Inhibitor for Tyrosine Protein Kinase From Pseudomonas.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy